{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:18:18Z","timestamp":1791332298582,"version":"4.3.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00115-025-01845-3","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T02:55:00Z","timestamp":1750992900000},"page":"403-415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Update Zwangsst\u00f6rungen und verwandte Erkrankungen","Update on obsessive-compulsive and related disorders"],"prefix":"10.1007","volume":"96","author":[{"given":"Dominique","family":"Endres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Baldermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam A.","family":"Schiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Voderholzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"issue":"1","key":"1845_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/mp.2008.94","volume":"15","author":"AM Ruscio","year":"2010","unstructured":"Ruscio\u00a0AM et\u00a0al (2010) The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 15(1):53\u201363. https:\/\/doi.org\/10.1038\/mp.2008.94","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1845_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","volume":"5","author":"DJ Stein","year":"2019","unstructured":"Stein\u00a0DJ et\u00a0al (2019) Obsessive-compulsive disorder. Nat Rev Dis Primers 5(1):52. https:\/\/doi.org\/10.1038\/s41572-019-0102-3","journal-title":"Nat Rev Dis Primers"},{"key":"1845_CR3","unstructured":"Endres D et\u00a0al Obsessive-compulsive disorder\u2014state of the art and new avenues for a personalized clinical approach. (Submitted)"},{"key":"1845_CR4","unstructured":"Endres D et\u00a0al Zwangsst\u00f6rungen \u2013 State of the art. https:\/\/www.springermedizin.de\/zoom-der-nervenarzt\/50609996. Zugegriffen: 23. M\u00e4rz 2025 (Nervenarzt, 1\/2025)"},{"key":"1845_CR5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM\u20115, 5.\u00a0Aufl. APA, Arlington","edition":"5"},{"key":"1845_CR6","unstructured":"World Health Organization (2024) International classification of diseases, eleventh revision (ICD-11). https:\/\/icd.who.int\/browse11. Zugegriffen: 23. M\u00e4rz 2025 (Version\u00a001\/2024)"},{"key":"1845_CR7","unstructured":"DGPPN (2022) S3\u00a0Leitlinie Zwangsst\u00f6rungen. https:\/\/register.awmf.org\/assets\/guidelines\/038_017l_S3_Zwangsst%C3%B6rungen_2022-07.pdf. Zugegriffen: 23. M\u00e4rz 2025"},{"issue":"2","key":"1845_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41380-022-01853-8","volume":"28","author":"D Endres","year":"2023","unstructured":"Endres\u00a0D et\u00a0al (2023) Obsessive-compulsive symptoms in two patients with strategic basal ganglia lesions. Mol Psychiatry 28(2):528\u2013531. https:\/\/doi.org\/10.1038\/s41380-022-01853-8","journal-title":"Mol Psychiatry"},{"issue":"7","key":"1845_CR9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s00115-022-01331-0","volume":"93","author":"D Endres","year":"2022","unstructured":"Endres\u00a0D et\u00a0al (2022) Neurobiology of obsessive-compulsive disorder. Nervenarzt 93(7):670\u2013677. https:\/\/doi.org\/10.1007\/s00115-022-01331-0","journal-title":"Nervenarzt"},{"issue":"10","key":"1845_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/ddg.12781","volume":"13","author":"P Mavrogiorgou","year":"2015","unstructured":"Mavrogiorgou\u00a0P et\u00a0al (2015) Obsessive-compulsive disorder in dermatology. J\u00a0Dtsch Dermatol Ges 13(10):991\u2013999. https:\/\/doi.org\/10.1111\/ddg.12781","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"1845_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41398-021-01700-4","volume":"12","author":"D Endres","year":"2022","unstructured":"Endres\u00a0D et\u00a0al (2022) Immunological causes of obsessive-compulsive disorder: Is it time for the concept of an \u201cautoimmune OCD\u201d subtype? Transl Psychiatry 12(1):5. https:\/\/doi.org\/10.1038\/s41398-021-01700-4","journal-title":"Transl Psychiatry"},{"key":"1845_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.schres.2023.03.024","volume":"255","author":"FP Martinho","year":"2023","unstructured":"Martinho\u00a0FP et\u00a0al (2023) Obsessive-compulsive symptoms in first episode psychosis and risk states: systematic review with meta-analysis. Schizophr Res 255:41\u201351. https:\/\/doi.org\/10.1016\/j.schres.2023.03.024","journal-title":"Schizophr Res"},{"issue":"3","key":"1845_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00406-021-01361-w","volume":"273","author":"MH Chen","year":"2023","unstructured":"Chen\u00a0MH et\u00a0al (2023) Diagnostic progression to schizophrenia in 35,255 patients with obsessive-compulsive disorder: a\u00a0longitudinal follow-up study. Eur Arch Psychiatry Clin Neurosci 273(3):541\u2013551. https:\/\/doi.org\/10.1007\/s00406-021-01361-w","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"7","key":"1845_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00115-022-01332-z","volume":"93","author":"F Schirmbeck","year":"2022","unstructured":"Schirmbeck\u00a0F, Zink\u00a0M (2022) Obsessive-compulsive symptoms in psychotic disorders: pathogenesis and treatment. Nervenarzt 93(7):688\u2013694. https:\/\/doi.org\/10.1007\/s00115-022-01332-z","journal-title":"Nervenarzt"},{"issue":"1","key":"1845_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12888-021-03458-x","volume":"21","author":"F K\u00fchne","year":"2021","unstructured":"K\u00fchne\u00a0F et\u00a0al (2021) Recognizing obsessive-compulsive disorder: How suitable is the German Zohar-Fineberg obsessive-compulsive screen? BMC Psychiatry 21(1):450. https:\/\/doi.org\/10.1186\/s12888-021-03458-x","journal-title":"BMC Psychiatry"},{"issue":"5","key":"1845_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s00115-024-01629-1","volume":"95","author":"D Endres","year":"2024","unstructured":"Endres\u00a0D et\u00a0al (2024) Treatment-resistant obsessive-compulsive disorders. Nervenarzt 95(5):432\u2013439. https:\/\/doi.org\/10.1007\/s00115-024-01629-1","journal-title":"Nervenarzt"},{"issue":"1","key":"1845_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/wps.20299","volume":"15","author":"D Mataix-Cols","year":"2016","unstructured":"Mataix-Cols\u00a0D et\u00a0al (2016) Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder. World Psychiatry 15(1):80\u201381. https:\/\/doi.org\/10.1002\/wps.20299","journal-title":"World Psychiatry"},{"issue":"175","key":"1845_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jpsychires.2024.04.052","volume":"26","author":"D Doolub","year":"2024","unstructured":"Doolub\u00a0D et\u00a0al (2024) Neurological soft signs as trait markers of a\u00a0subset of patients with obsessive-compulsive disorder with low insight and altered cognitive abilities. J\u00a0Psychiatr Res 26(175):42\u201349. https:\/\/doi.org\/10.1016\/j.jpsychires.2024.04.052","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1845_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41398-023-02368-8","volume":"13","author":"K Runge","year":"2023","unstructured":"Runge\u00a0K et\u00a0al (2023) Deep clinical phenotyping of patients with obsessive-compulsive disorder: an approach towards detection of organic causes and first results. Transl Psychiatry 13(1):83. https:\/\/doi.org\/10.1038\/s41398-023-02368-8","journal-title":"Transl Psychiatry"},{"key":"1845_CR20","unstructured":"Koran LM, Simpson HB (2013) Practice guideline for the treatment of patients with obsessive-compulsive disorder. https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/ocd-watch.pdf. Zugegriffen: 23. M\u00e4rz 2025 (APA Practice Guidelines)"},{"key":"1845_CR21","unstructured":"National Institute for Health and Care Excellence (2005) Obsessive-compulsive disorder and body dysmorphic disorder: treatment (NICE guideline CG\u00a031). https:\/\/www.nice.org.uk\/guidance\/cg31\/resources\/obsessivecompulsive-disorder-and-body-dysmorphic-disorder-treatment-pdf-975381519301. Zugegriffen: 23. M\u00e4rz 2025"},{"issue":"2","key":"1845_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000520454","volume":"91","author":"N Kathmann","year":"2022","unstructured":"Kathmann\u00a0N et\u00a0al (2022) Effectiveness of individual cognitive-behavioral therapy and predictors of outcome in adult patients with obsessive-compulsive disorder. Psychother Psychosom 91(2):123\u2013135. https:\/\/doi.org\/10.1159\/000520454","journal-title":"Psychother Psychosom"},{"key":"1845_CR23","doi-asserted-by":"publisher","first-page":"152223","DOI":"10.1016\/j.comppsych.2021.152223","volume":"106","author":"JE Reid","year":"2021","unstructured":"Reid\u00a0JE et\u00a0al (2021) Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: a\u00a0systematic review and meta-analysis of randomised controlled trials. Compr Psychiatry 106:152223. https:\/\/doi.org\/10.1016\/j.comppsych.2021.152223","journal-title":"Compr Psychiatry"},{"issue":"11","key":"1845_CR24","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1017\/S0033291724001375","volume":"54","author":"Y Wang","year":"2024","unstructured":"Wang\u00a0Y et\u00a0al (2024) The effectiveness of psychological treatments for obsessive-compulsive disorders: a\u00a0meta-analysis of randomized controlled trials published over last 30\u00a0years. Psychol Med 54(11):2838\u20132851. https:\/\/doi.org\/10.1017\/S0033291724001375","journal-title":"Psychol Med"},{"issue":"8","key":"1845_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","volume":"3","author":"P Skapinakis","year":"2016","unstructured":"Skapinakis\u00a0P et\u00a0al (2016) Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a\u00a0systematic review and network meta-analysis. Lancet Psychiatry 3(8):730\u2013739. https:\/\/doi.org\/10.1016\/S2215-0366(16)30069-4","journal-title":"Lancet Psychiatry"},{"key":"1845_CR26","doi-asserted-by":"publisher","first-page":"102711","DOI":"10.1016\/j.janxdis.2023.102711","volume":"96","author":"H Kim","year":"2023","unstructured":"Kim\u00a0H et\u00a0al (2023) Identifying trajectories of symptom change in adults with obsessive compulsive disorder receiving exposure and response prevention therapy. J\u00a0Anxiety Disord 96:102711. https:\/\/doi.org\/10.1016\/j.janxdis.2023.102711","journal-title":"J Anxiety Disord"},{"issue":"3","key":"1845_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1891\/JCPSY-D-20-00002","volume":"34","author":"AK K\u00fclz","year":"2020","unstructured":"K\u00fclz\u00a0AK et\u00a0al (2020) Long-term follow-up of cognitive-behavioral therapy for obsessive-compulsive disorder: symptom severity and the role of exposure 8\u201310 years after inpatient treatment. J\u00a0Cogn Psychother 34(3):261\u2013271. https:\/\/doi.org\/10.1891\/JCPSY-D-20-00002","journal-title":"J Cogn Psychother"},{"key":"1845_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jpsychires.2024.06.007","volume":"176","author":"EM Zisler","year":"2024","unstructured":"Zisler\u00a0EM et\u00a0al (2024) Effects of inpatient, residential, and day-patient treatment on obsessive-compulsive symptoms in persons with obsessive-compulsive disorder: a\u00a0systematic review and meta-analysis. J\u00a0Psychiatr Res 176:182\u2013197. https:\/\/doi.org\/10.1016\/j.jpsychires.2024.06.007","journal-title":"J Psychiatr Res"},{"key":"1845_CR29","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3389\/fpsyg.2019.02500","volume":"10","author":"G Launes","year":"2019","unstructured":"Launes\u00a0G et\u00a0al (2019) A\u00a0randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4\u2011day treatment. Front Psychol 10:2500. https:\/\/doi.org\/10.3389\/fpsyg.2019.02500","journal-title":"Front Psychol"},{"key":"1845_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocrd.2024.100913","author":"L Jelinek","year":"2024","unstructured":"Jelinek\u00a0L et\u00a0al (2024) Exploring the peaks and potholes: understanding positive and negative effects of concentrated exposure treatment for obsessive-compulsive disorder. J\u00a0Obsessive Compuls Relat Disord. https:\/\/doi.org\/10.1016\/j.jocrd.2024.100913","journal-title":"J Obsessive Compuls Relat Disord"},{"key":"1845_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jpsychires.2023.10.025","volume":"168","author":"W Zhang","year":"2023","unstructured":"Zhang\u00a0W (2023) Comparison of internet-based and face-to-face cognitive behavioral therapy for obsessive-compulsive disorder: a\u00a0systematic review and network meta-analysis. J\u00a0Psychiatr Res 168:140\u2013148. https:\/\/doi.org\/10.1016\/j.jpsychires.2023.10.025","journal-title":"J Psychiatr Res"},{"issue":"5","key":"1845_CR32","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.4088\/JCP.14r09758","volume":"77","author":"Y Issari","year":"2016","unstructured":"Issari\u00a0Y et\u00a0al (2016) Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a\u00a0meta-analysis. J\u00a0Clin Psychiatry 77(5):e605\u2013e611. https:\/\/doi.org\/10.4088\/JCP.14r09758","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"1845_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/da.22737","volume":"35","author":"YA de Vries","year":"2018","unstructured":"de Vries\u00a0YA et\u00a0al (2018) Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: an individual patient data meta-analysis. Depress Anxiety 35(6):515\u2013522. https:\/\/doi.org\/10.1002\/da.22737","journal-title":"Depress Anxiety"},{"issue":"1","key":"1845_CR34","doi-asserted-by":"publisher","first-page":"e300951","DOI":"10.1136\/bmjment-2023-300951","volume":"27","author":"SE Cohen","year":"2024","unstructured":"Cohen\u00a0SE et\u00a0al (2024) Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: a\u00a0systematic review and meta-analysis of randomised, placebo-controlled trials. BMJ Ment Health 27(1):e300951. https:\/\/doi.org\/10.1136\/bmjment-2023-300951","journal-title":"BMJ Ment Health"},{"issue":"3","key":"1845_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/jamapsychiatry.2021.3997","volume":"79","author":"EB Foa","year":"2022","unstructured":"Foa\u00a0EB et\u00a0al (2022) Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure\/response prevention augmentation: a\u00a0randomized clinical trial. JAMA Psychiatry 79(3):193\u2013200. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.3997","journal-title":"JAMA Psychiatry"},{"key":"1845_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jpsychires.2019.01.014","volume":"111","author":"DD Zhou","year":"2019","unstructured":"Zhou\u00a0DD et\u00a0al (2019) Comparative efficacy and tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive disorder: a\u00a0network meta-analysis. J\u00a0Psychiatr Res 111:51\u201358. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.01.014","journal-title":"J Psychiatr Res"},{"key":"1845_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/7854_2020_204","volume":"49","author":"C Pittenger","year":"2021","unstructured":"Pittenger\u00a0C (2021) Pharmacotherapeutic strategies and new targets in OCD. Curr Top Behav Neurosci 49:331\u2013384. https:\/\/doi.org\/10.1007\/7854_2020_204","journal-title":"Curr Top Behav Neurosci"},{"issue":"11","key":"1845_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s11920-014-0510-8","volume":"16","author":"TM Fonseka","year":"2014","unstructured":"Fonseka\u00a0TM et\u00a0al (2014) Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a\u00a0review of the experimental literature. Curr Psychiatry Rep 16(11):510. https:\/\/doi.org\/10.1007\/s11920-014-0510-8","journal-title":"Curr Psychiatry Rep"},{"key":"1845_CR39","doi-asserted-by":"publisher","first-page":"152352","DOI":"10.1016\/j.comppsych.2022.152352","volume":"120","author":"PJ van Roessel","year":"2023","unstructured":"van Roessel\u00a0PJ et\u00a0al (2023) Treatment-resistant OCD: pharmacotherapies in adults. Compr Psychiatry 120:152352. https:\/\/doi.org\/10.1016\/j.comppsych.2022.152352","journal-title":"Compr Psychiatry"},{"issue":"1","key":"1845_CR40","doi-asserted-by":"publisher","first-page":"e2452963","DOI":"10.1001\/jamanetworkopen.2024.52963","volume":"8","author":"DRA Coelho","year":"2025","unstructured":"Coelho\u00a0DRA et\u00a0al (2025) Glutamatergic medications for obsessive-compulsive and related disorders: a\u00a0systematic review and meta-analysis. JAMA Netw Open 8(1):e2452963. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.52963","journal-title":"JAMA Netw Open"},{"issue":"11","key":"1845_CR41","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1176\/appi.ajp.2019.18101180","volume":"176","author":"L Carmi","year":"2019","unstructured":"Carmi\u00a0L et\u00a0al (2019) Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a\u00a0prospective multicenter randomized double-blind placebo-controlled trial. Am J Psychiatry 176(11):931\u2013938. https:\/\/doi.org\/10.1176\/appi.ajp.2019.18101180","journal-title":"Am J Psychiatry"},{"key":"1845_CR42","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jad.2022.01.048","volume":"302","author":"SMDD Fitzsimmons","year":"2022","unstructured":"Fitzsimmons\u00a0SMDD et\u00a0al (2022) Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: a\u00a0systematic review and pairwise\/network meta-analysis. J\u00a0Affect Disord 302:302\u2013312. https:\/\/doi.org\/10.1016\/j.jad.2022.01.048","journal-title":"J Affect Disord"},{"issue":"11","key":"1845_CR43","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/jnnp-2021-328738","volume":"93","author":"R Gadot","year":"2022","unstructured":"Gadot\u00a0R et\u00a0al (2022) Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis. J\u00a0Neurol Neurosurg Psychiatry 93(11):1166\u20131173. https:\/\/doi.org\/10.1136\/jnnp-2021-328738","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"1845_CR44","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.biopsych.2020.08.018","volume":"90","author":"I Graat","year":"2021","unstructured":"Graat\u00a0I et\u00a0al (2021) Long-term outcome of deep brain stimulation of the ventral part of the anterior limb of the internal capsule in a\u00a0cohort of 50\u00a0patients with treatment-refractory obsessive-compulsive disorder. Biol Psychiatry 90(10):714\u2013720. https:\/\/doi.org\/10.1016\/j.biopsych.2020.08.018","journal-title":"Biol Psychiatry"},{"issue":"10","key":"1845_CR45","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.biopsych.2021.07.010","volume":"90","author":"JC Baldermann","year":"2021","unstructured":"Baldermann\u00a0JC et\u00a0al (2021) Connectomic deep brain stimulation for obsessive-compulsive disorder. Biol Psychiatry 90(10):678\u2013688. https:\/\/doi.org\/10.1016\/j.biopsych.2021.07.010","journal-title":"Biol Psychiatry"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01845-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-025-01845-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01845-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:46:42Z","timestamp":1757198802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-025-01845-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1845"],"URL":"https:\/\/doi.org\/10.1007\/s00115-025-01845-3","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"7 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"D.\u00a0Endres: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung von der Deutschen Forschungsgemeinschaft (DFG; 419859038) und dem Bundesministerium f\u00fcr Bildung und Forschung (BMBF; 01GM2208, CONNECTGENERATE).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Gesch\u00e4ftsf\u00fchrender Oberarzt in der Klinik f\u00fcr Psychiatrie und Psychotherapie, Universit\u00e4tsklinikum Freiburg\u00a0| Referateleiter bei der Deutschen Gesellschaft f\u00fcr Biologische Psychiatrie (DGBP). K.\u00a0Domschke: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: DFG. \u2013 Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: Janssen Inc. \u2013 Bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u00c4.: Janssen Inc.; Neurotorium Editorial Board, Lundbeck.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: \u00c4rztliche Direktorin Klinik f\u00fcr Psychiatrie und Psychotherapie, Universit\u00e4tsklinikum Freiburg\u00a0| Mitglied im Vorstand der Deutschen Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN), Mitglied im Vorstand des Freiburger Ausbildungsinstituts f\u00fcr Verhaltenstherapie (FAVT), Mitglied im Neurotorium Editorial Board, Lundbeck. J.C.\u00a0Baldermann: A.\u00a0Finanzielle Interessen: Exzellenzstipendium der Else-Kr\u00f6ner-Fresenius-Stiftung (2022_EKES.23), F\u00f6rderung durch die Deutsche Forschungsgemeinschaft (SFB 1451, Projekt 431549029-C07).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Psychiater, Klinik f\u00fcr Psychiatrie und Psychotherapie, Universit\u00e4tsklinik Freiburg\u00a0| Mitgliedschaften: Deutsche Tourette-Gesellschaft Deutschland e.V., Mitglied der Sektion f\u00fcr Transkranielle und Tiefe Hirnstimulation des DGPPN-Referates Hirnstimulationsverfahren, Mitglied der Arbeitsgemeinschaft Tiefe Hirnstimulation e.V. M.\u00a0Schiele: A.\u00a0Finanzielle Interessen: M. Schiele gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Leitende Psychologin, Klinik f\u00fcr Psychiatrie und Psychotherapie, Universit\u00e4tsklinikum Freiburg\u00a0| Mitgliedschaften: European College of Neuropsychopharmacology (ECNP), Deutsche Gesellschaft f\u00fcr Psychologie (DGPs), DGPPN, DGBP, Deutsche PsychotherapeutenVereinigung (DPtV), BPK, Arbeitsgemeinschaft f\u00fcr Verhaltensmodifikation (AVM). L. Jelinek: A.\u00a0Finanzielle Interessen: Peter M\u00f6hrle Foundation: Funding of a randomized controlled trial \u201eHamburg concentrated Exposure and Response prevention treatment for OCD\u201c (HERO), BMBF: Funding of the development of a concept for KOMPAKT, Werner Otto foundation (WOI): Funding of a clinical trial on the treatment mechanism of the Bergen 4\u2011day OCD Treatment (B4DT), Hamburger Spendenparlament: Funding of compact treatment for OCD (therapist). \u2013 Weiterbildungsseminar (Dozentin): Institut f\u00fcr Psychotherapie (IfP).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Leitung Forschungsbereich Neuropsychologie und Psychotherapie\/Leitung Arbeitsgruppe Angst- und Zwangsst\u00f6rungen, Universit\u00e4tsklinikum Hamburg-Eppendorf, Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie , Martinistra\u00dfe 52, 20246 Hamburg\u00a0| Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Psychologie (DGPs), Fachgruppe Klinische Psychologie; Deutsche Gesellschaft f\u00fcr Verhaltenstherapie (DGVT); Deutsche Gesellschaft Zwangserkrankungen (DGZ); Center for Health Care Research (CHCR). U.\u00a0Voderholzer: A.\u00a0Finanzielle Interessen: iCAN-Studie (Innovationsfonds-Studie), FIAT-Studie (Innovationsfonds-Studie).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: \u00c4rztlicher Direktor\/Chefarzt Sch\u00f6n Klinik Roseneck, Prien a. Chiemsee, in Zusammenarbeit mit der Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie Universit\u00e4tsklinikum M\u00fcnchen (Science Office)\u00a0| 1. Vorsitzender des Wissenschaftlichen Beirates Deutsche Gesellschaft Zwangserkrankungen e.V. (DGZ), Leiter der Deutschen Leitlinienkommission S3-Leitlinie Zwangsst\u00f6rungen der Deutschen Gesellschaft f\u00fcr Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN), Leiter des Referates Psychosomatik der DGPPN, Mitarbeiter des Referates Psychotherapie der DGPPN, Vorsitzender der Sektion Essst\u00f6rungen der Word Psychiatric Association (WPA), Sprecher des Bundesfachverbandes Essst\u00f6rungen (BFE), Leiter der Arbeitsgruppe Innovation, Wissenschaft und Forschung (AG IWF) der Psychosomatischen Kliniken der Sch\u00f6n Klinik und Leiter des Science Office Psychiatrie, Psychosomatik und Psychotherapie der Sch\u00f6n Klinik.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"Ein Ethikvotum war nicht notwendig, da es sich um einen Fortbildungsartikel handelt. Die Patientin, die in der Kurzkasuistik beschrieben wird, hat der Fallbeschreibung schriftlich zugestimmt.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}